Staphylococcus aureus sepsis in rheumatoid arthritis

Rheumatology International
Michael SamsPrabha Ranganathan

Abstract

Patients with rheumatoid arthritis (RA) are at increased risk of infection. In this study, we determined the risk of and risk factors for Staphyococcus aureus (S. aureus) sepsis in RA. We assembled a retrospective nested case-control subset of RA patients with S. aureus sepsis from the Barnes-Jewish Hospital Medical Informatics database, confirmed the diagnoses, and collected data electronically and by chart review. We used multivariate logistic regression to identify independent risk factors for S. aureus sepsis, with risk expressed as odds ratios (ORs). We extracted data on the length of hospitalization and 30-day and 1-year mortality from the Medical Informatics database for all cases and controls. There were 48 confirmed S. aureus sepsis cases and 232 confirmed controls in the RA cohort. In multivariate analysis, indwelling central venous catheter (OR 15.97; 95 % CI 5.09-50.10; p < 0.01) and congestive heart failure (OR 2.89; 95 % CI 1.26-6.63; p = 0.01) were independently associated with risk of S. aureus sepsis, while treatment with disease-modifying anti-rheumatic drugs (DMARDs), both biologic and non-biologic, was not. S. aureus sepsis was associated with increased 30-day and 1-year mortality (OR 7.37; 95 % CI 2.86-19.0...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Sep 25, 2003·Archives of Internal Medicine·Vance G FowlerEugene Z Oddone
Mar 17, 2007·Scandinavian Journal of Infectious Diseases·Gunnar JacobssonRune Andersson
Jan 4, 2008·The Journal of Bone and Joint Surgery. American Volume·Margaret A OlsenVictoria J Fraser
May 31, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Margaret A OlsenVictoria J Fraser
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Oct 14, 2009·Annals of the Rheumatic Diseases·N Akhmed, J Lichtenstein
Oct 18, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M BassettiM Tumbarello
Nov 8, 2011·JAMA : the Journal of the American Medical Association·Carlos G GrijalvaJeffrey R Curtis
Jan 10, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Julie D LankiewiczSusan S Huang
Feb 14, 2013·The Journal of Antimicrobial Chemotherapy·O GaschUNKNOWN REIPI/GEIH Study Groups
Mar 7, 2013·Southern Medical Journal·Virginia FlemingRobin Southwood
Aug 8, 2013·The Journal of Infection·Pierre LoulergueUNKNOWN RATIO Group
Apr 10, 2014·JAMA : the Journal of the American Medical Association·Preeti N Malani

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.